155 related articles for article (PubMed ID: 20509715)
1. Dapagliflozin: BMS 512148; BMS-512148.
Drugs R D; 2010; 10(1):47-54. PubMed ID: 20509715
[TBL] [Abstract][Full Text] [Related]
2. Dapagliflozin, an oral sodium glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.
Calado J
IDrugs; 2009 Dec; 12(12):785-98. PubMed ID: 19943222
[TBL] [Abstract][Full Text] [Related]
3. Dapagliflozin, an SGLT2 inhibitor for the treatment of type 2 diabetes.
Demaris KM; White JR
Drugs Today (Barc); 2013 May; 49(5):289-301. PubMed ID: 23724409
[TBL] [Abstract][Full Text] [Related]
4. Dapagliflozin for the treatment of type 2 diabetes.
Anderson SL; Marrs JC
Ann Pharmacother; 2012 Apr; 46(4):590-8. PubMed ID: 22433611
[TBL] [Abstract][Full Text] [Related]
5. Molecule of the month. Dapagliflozin.
Drug News Perspect; 2007 Dec; 20(10):645. PubMed ID: 18301798
[No Abstract] [Full Text] [Related]
6. [Sodium-glucose co-transporter-2 inhibitors: from the bark of apple trees and familial renal glycosuria to the treatment of type 2 diabetes mellitus].
Mauricio D
Med Clin (Barc); 2013 Sep; 141 Suppl 2():31-5. PubMed ID: 24444522
[TBL] [Abstract][Full Text] [Related]
7. SGLT2 inhibition with dapagliflozin -- a novel approach for the management of type 2 diabetes.
Kilov G; Leow S; Thomas M
Aust Fam Physician; 2013 Oct; 42(10):706-10. PubMed ID: 24130972
[TBL] [Abstract][Full Text] [Related]
8. A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus.
Avogaro A; Giaccari A; Fioretto P; Genovese S; Purrello F; Giorgino F; Del Prato S
Expert Rev Clin Pharmacol; 2017 Jul; 10(7):763-772. PubMed ID: 28431476
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin: a new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes.
Vivian EM
Am J Health Syst Pharm; 2015 Mar; 72(5):361-72. PubMed ID: 25694411
[TBL] [Abstract][Full Text] [Related]
10. A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors.
Chao EC
Discov Med; 2011 Mar; 11(58):255-63. PubMed ID: 21447284
[TBL] [Abstract][Full Text] [Related]
11. Dapagliflozin: A Sodium Glucose Cotransporter 2 Inhibitor for the Treatment of Diabetes Mellitus.
Davis PN; Ndefo UA; Oliver A
J Pharm Pract; 2016 Apr; 29(2):165-71. PubMed ID: 25609661
[TBL] [Abstract][Full Text] [Related]
12. Dapagliflozin, an SGLT2 inhibitor, for diabetes.
Hanefeld M; Forst T
Lancet; 2010 Jun; 375(9733):2196-8. PubMed ID: 20609956
[No Abstract] [Full Text] [Related]
13. Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.
Scheen AJ
Drugs; 2015 Jan; 75(1):33-59. PubMed ID: 25488697
[TBL] [Abstract][Full Text] [Related]
14. [Renal SGLT2 inhibitors: a new type of oral anti-hyperglycemia drugs].
Zhang WB; Gong N; Wang YX
Sheng Li Ke Xue Jin Zhan; 2010 Dec; 41(6):453-6. PubMed ID: 21416966
[No Abstract] [Full Text] [Related]
15. Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders.
Shaikh S; Rizvi SM; Shakil S; Riyaz S; Biswas D; Jahan R
Biotechnol Appl Biochem; 2016; 63(1):145-50. PubMed ID: 25402624
[TBL] [Abstract][Full Text] [Related]
16. Sodium-glucose co-transporter 2 inhibition in diabetes treatment: current evidence and future perspectives.
Rizos EC; Elisaf MS
Curr Pharm Des; 2014; 20(22):3647-56. PubMed ID: 24040872
[TBL] [Abstract][Full Text] [Related]
17. Sodium glucose co-transporter 2 inhibitors and their mechanism for improving glycemia in patients with type 2 diabetes.
Davidson JA; Kuritzky L
Postgrad Med; 2014 Oct; 126(6):33-48. PubMed ID: 25414933
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin for the treatment of type 2 diabetes.
Brooks AM; Thacker SM
Ann Pharmacother; 2009 Jul; 43(7):1286-93. PubMed ID: 19584379
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin: a review on efficacy, clinical effectiveness and safety.
Paisley AN; Yadav R; Younis N; Rao-Balakrishna P; Soran H
Expert Opin Investig Drugs; 2013 Jan; 22(1):131-40. PubMed ID: 23127205
[TBL] [Abstract][Full Text] [Related]
20. Design of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: A History Driven by Biology to Chemistry.
Cai W; Jiang L; Xie Y; Liu Y; Liu W; Zhao G
Med Chem; 2015; 11(4):317-28. PubMed ID: 25557661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
